Literature DB >> 833962

Sex cord-stromal (gonadal stromal) tumors of the testis: a report of 5 cases.

F F Marshall, W S Kerr, B Kliman, R E Scully.   

Abstract

Sex cord-stromal (gonadal stromal) tumors of the testis account for less than 4 per cent of the testicular tumors. The Leydig cell tumor in a child may produce isosexual virilization (case 3). In the adult it may have no endocrine manifestation (case 1) or gynecomastia and decrease in libidio may result from production of estrogens (case 2). Sertoli cell tumors (case 4) and granulosa cell tumors (case5) are rare.

Entities:  

Mesh：

Year:  1977        PMID： 833962     DOI： 10.1016/s0022-5347(17)58389-5

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  Malignant Leydig cell tumour of the testis: a case report and review of the literature.

Authors:  E Unlüer; D Ozcan; S Altin
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  A malignant mixed gonadal stromal tumour of the testis with heterologous components.

Authors:  H Ustun; E Tekakca; M Caydere; H Pulat; D Erol
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  Testicular sex cord stromal tumour with granulosa cell differentiation: detection of steroid hormone receptors as a possible basis for tumour development and therapeutic management.

Authors:  W Düe; K P Dieckmann; G Niedobitek; G Bornhöft; V Loy; H Stein
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

Review 4.  Adult-type granulosa cell tumour of the testis: Report of a case and review of the literature.

Authors:  Osama Al-Alao; Tawiz Gul; Ammar Al-Ani; Issam A Bozom; Khalid Al-Jalham
Journal:  Arab J Urol       Date:  2016-02-06

Review 5.  Adult type granulosa cell tumor of the testis with a heterologous sarcomatous component: case report and review of the literature.

Authors:  Thomas E O Schubert; Robert Stoehr; Arndt Hartmann; Sabrina Schöne; Mathias Löbelenz; Gregor Mikuz
Journal:  Diagn Pathol       Date:  2014-06-03       Impact factor: 2.644
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.